Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis
V Takiar, S Nishio, P Seo-Mayer… - Proceedings of the …, 2011 - National Acad Sciences
Renal cyst development and expansion in autosomal dominant polycystic kidney disease (ADPKD)
involves both fluid secretion and abnormal proliferation of cyst-lining epithelial cells. …
involves both fluid secretion and abnormal proliferation of cyst-lining epithelial cells. …
Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial
…, TJ Pugh, H Skinner, LB Levy, V Takiar… - International Journal of …, 2014 - Elsevier
Objective To report late toxicity outcomes from a randomized trial comparing conventional
and hypofractionated prostate radiation therapy and to identify dosimetric and clinical …
and hypofractionated prostate radiation therapy and to identify dosimetric and clinical …
Reirradiation of head and neck cancers with proton therapy: outcomes and analyses
J Phan, TT Sio, TP Nguyen, V Takiar, GB Gunn… - International Journal of …, 2016 - Elsevier
Purpose Reirradiation of head and neck (H&N) cancer is a clinical challenge. Proton radiation
therapy (PRT) offers dosimetric advantages for normal tissue sparing and may benefit …
therapy (PRT) offers dosimetric advantages for normal tissue sparing and may benefit …
Phase II clinical trial of neoadjuvant and adjuvant pembrolizumab in resectable local–regionally advanced head and neck squamous cell carcinoma
…, M Medvedovic, JJ Lee, N Harun, V Takiar… - Clinical Cancer …, 2022 - AACR
Purpose: Patients with resected, local–regionally advanced, head and neck squamous cell
carcinoma (HNSCC) have a one-year disease-free survival (DFS) rate of 65%–69% despite …
carcinoma (HNSCC) have a one-year disease-free survival (DFS) rate of 65%–69% despite …
Reirradiation of head and neck cancers with intensity modulated radiation therapy: outcomes and analyses
V Takiar, AS Garden, D Ma, WH Morrison… - International Journal of …, 2016 - Elsevier
Purpose To review our 15-year institutional experience using intensity modulated radiation
therapy (IMRT) to reirradiate patients with head and neck squamous cell carcinomas (HNSCC…
therapy (IMRT) to reirradiate patients with head and neck squamous cell carcinomas (HNSCC…
Osteoradionecrosis: Exposing the evidence not the bone
…, B Cervenka, AL Tang, DG Krishnan, V Takiar - International Journal of …, 2021 - Elsevier
Osteoradionecrosis is a relatively rare but potentially morbid and costly complication of
radiation therapy for head and neck cancer. Multidisciplinary diagnosis and treatment are …
radiation therapy for head and neck cancer. Multidisciplinary diagnosis and treatment are …
[HTML][HTML] Polycystic kidney disease: pathogenesis and potential therapies
V Takiar, MJ Caplan - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2011 - Elsevier
Autosomal dominant polycystic kidney disease (ADPKD) is a prevalent, inherited condition
for which there is currently no effective specific clinical therapy. The disease is characterized …
for which there is currently no effective specific clinical therapy. The disease is characterized …
Female representation in otolaryngology leadership roles
…, CJ Gouveia, ME Tabangin, V Takiar… - The …, 2020 - Wiley Online Library
Objectives/Hypothesis Characterization of leadership within otolaryngology is key to evaluating
trends and promoting program advancement. This study evaluates representation of …
trends and promoting program advancement. This study evaluates representation of …
Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma …
The efficacy of ionizing radiation (IR) for head and neck cancer squamous cell carcinoma (HNSCC)
is limited by poorly understood mechanisms of adaptive radioresistance. Elevated …
is limited by poorly understood mechanisms of adaptive radioresistance. Elevated …
[HTML][HTML] Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
…, J Curry, U Martinez-Outschoorn, V Takiar… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
… McKenzie Crist, 1 Benyamin Yaniv, 2 Sarah Palackdharry, 3 Maria A Lehn, 1, 4 Mario
Medvedovic, 5 Timothy Stone, 5 Shuchi Gulati, 1 Vidhya Karivedu, 6 Michael Borchers, 7, 8 …
Medvedovic, 5 Timothy Stone, 5 Shuchi Gulati, 1 Vidhya Karivedu, 6 Michael Borchers, 7, 8 …